Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Sarcoma
>>
Tyrosine Kinase Inhibitors
>>
Phase 3
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
10
20
30
40
50
60
70
80
90
100
Avastin
(bevacizumab) / Roche
sorafenib
/ Generic mfg.
Cabometyx
(cabozantinib tablet) / Exelixis, Ipsen
Lartruvo
(olaratumab) / Eli Lilly
Erbitux
(cetuximab) / Eli Lilly, EMD Serono
Qinlock
(ripretinib) / Ono Pharma
Cometriq
(cabozantinib capsule) / Exelixis, Ipsen
ganitumab
(AMG 479) / Takeda, ImmunityBio
Herceptin
(trastuzumab) / Roche
Vectibix
(panitumumab) / Amgen
famitinib
(SHR 1020) / Jiangsu Hengrui Pharma
lapatinib
/ Generic mfg.
Kinaction
(masitinib) / AB Science
Lytgobi
(futibatinib) / Otsuka
carotuximab IV
(ENV-105) / Kairos Pharma
Perjeta
(pertuzumab) / Roche
Tabrecta
(capmatinib) / Incyte, Novartis
bezuclastinib
(PLX9486) / Cogent Biosci
Phesgo
(pertuzumab/trastuzumab/hyaluronidase-zzxf) / Roche
Rintega
(rindopepimut) / Celldex
Zykadia
(ceritinib) / Novartis
crenolanib
(ARO-002) / AROG
depatuxizumab mafodotin
(ABT-414) / AbbVie
